OrbiMed’s ADARx Pharmaceuticals ADRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$483M Buy
+24,205,789
New +$484M 8.78% 2

Other funds holding ADRX

OrbiMed's ADRX Position: Q3 2026 in Review

OrbiMed opened a new position in ADARx Pharmaceuticals (ADRX) in Q3 2026: 24,205,789 shares worth $483M. The stake represents 8.78% of the portfolio and ranks #2 among its holdings.

62 funds tracked by Wall St. Rank hold ADRX as of Q3 2026.

  • OrbiMed held 24,205,789 shares of ADARx Pharmaceuticals worth $483M as of Q3 2026.
  • ADARx Pharmaceuticals was a new OrbiMed position in Q3 2026.
  • ADARx Pharmaceuticals made up 8.78% of OrbiMed's portfolio in Q3 2026, its #2 holding.
  • 62 funds tracked by Wall St. Rank held ADARx Pharmaceuticals as of Q3 2026.

Based on OrbiMed's 13F filing for Q3 2026, filed 16 Nov 2026.